IDEXX Laboratories Inc (IDXX) has a current Price-to-Book (P/B) ratio of 34.33. Compared to its 3-year average P/B ratio of 31.63, the current P/B ratio is approximately 8.54% higher. Relative to its 5-year average P/B ratio of 46.25, the current P/B ratio is about -25.77% higher. IDEXX Laboratories Inc (IDXX) has a Forward Free Cash Flow (FCF) yield of approximately 1.80%. Compared to its 3-year average FCF yield of 1.81%, the current FCF yield is approximately -0.50% lower. Relative to its 5-year average FCF yield of 1.63%, the current FCF yield is about 10.33% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for IDXX competitors is 4.98, providing a benchmark for relative valuation. IDEXX Laboratories Inc Corp (IDXX.O) exhibits a P/S ratio of 11.74, which is 135.53% above the industry average. Given its robust revenue growth of 14.28%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of IDXX increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of IDXX in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is IDXX currently overvalued or undervalued?

What is IDEXX Laboratories Inc (IDXX) fair value?

IDXX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of IDEXX Laboratories Inc (IDXX) is between 473.27 to 734.88 according to relative valuation method.

How does IDXX's valuation metrics compare to the industry average?

The average P/S ratio for IDXX's competitors is 4.98, providing a benchmark for relative valuation. IDEXX Laboratories Inc Corp (IDXX) exhibits a P/S ratio of 11.74, which is 135.53% above the industry average. Given its robust revenue growth of 14.28%, this premium appears unsustainable.

What is the current P/B ratio for IDEXX Laboratories Inc (IDXX) as of Mar 02 2026?

As of Mar 02 2026, IDEXX Laboratories Inc (IDXX) has a P/B ratio of 34.33. This indicates that the market values IDXX at 34.33 times its book value.

What is the current FCF Yield for IDEXX Laboratories Inc (IDXX) as of Mar 02 2026?

As of Mar 02 2026, IDEXX Laboratories Inc (IDXX) has a FCF Yield of 1.80%. This means that for every dollar of IDEXX Laboratories Inc's market capitalization, the company generates 1.80 cents in free cash flow.

What is the current Forward P/E ratio for IDEXX Laboratories Inc (IDXX) as of Mar 02 2026?

As of Mar 02 2026, IDEXX Laboratories Inc (IDXX) has a Forward P/E ratio of 47.56. This means the market is willing to pay $47.56 for every dollar of IDEXX Laboratories Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for IDEXX Laboratories Inc (IDXX) as of Mar 02 2026?

As of Mar 02 2026, IDEXX Laboratories Inc (IDXX) has a Forward P/S ratio of 11.74. This means the market is valuing IDXX at $11.74 for every dollar of expected revenue over the next 12 months.

IDXX Valuation